Archive →
Daily Morning Briefing

Saturday, 16 May 2026

Bond rout catches up with Wall St — S&P worst day since March on Friday · UK gilts at post-2008 stress as Burnham clears path to challenge Starmer · Trump–Xi summit ends with truce extension but no Taiwan, Iran or rare-earths breakthrough · Russia hits Kyiv apartment block, 24 dead · Germany halves 2026 growth forecast on Iran fallout
Europe/Rome 06:00 · Cash markets closed — weekend · Inflation-led repricing dominates the tape · Week ahead: FOMC minutes Wed · Nvidia earnings Wed · Walmart Thu

Top of the morning

Markets snapshot — Friday close (cash markets closed for weekend)

Levels reflect Friday 15 May 2026 close, cross-referenced from the FT homepage ticker (read live via Control Chrome on Luca's open tab) and from Bloomberg / CNBC / Yahoo Finance reporting on the session. Weekend tape; no live prints.

InstrumentLastFriday change / context
S&P 5007,408.50−1.24% · worst day since March
Nasdaq Composite26,225.14−1.54% · tech leading the slide
Dow Jones49,526.17−1.07% · −537 pts
FTSE 100−1.71% · gilts under stress
Shanghai Composite−1.02%
Nikkei 22561,409.29−2.00% · Topix −0.39% to 3,864
Hang Seng−1.6%
CSI 3004,859.59−1.12%
US 10y Treasury4.59%+~9bp · highest since Feb 2025
US 2y Treasury4.09%also highest since Feb 2025
UK 10y Gilt5.12%+13bp · biggest weekly move since March
Brent crude (front-month)$106.89+~1% · Hormuz week 12 · weekly gain
Gold (XAU spot)$4,564−1.83% · 4th straight session lower
Silver (XAG spot)$77.52−10.61% · sharp risk-off rotation
EUR/USD~1.173−0.40% on the day
GBP/USD~1.335worst week vs USD since 2024
Bitcoin~$79,000dipped below $79k on inflation fears

Geopolitics & the weekend backdrop

The summit's close yields a useful framing: substance is moving on trade (truce extension, beef plants reopened, agricultural-purchase expectations) but stalling on the strategic files (Taiwan arms decision pending, no rare-earths concessions, no concrete Iran mechanism). Beijing's public call to reopen Hormuz is the most macro-relevant line — if it translates into Chinese pressure on Tehran or a quiet pullback from buying Iranian crude, it would be the first plausible diplomatic off-ramp for the oil shock since week one. The base case for now remains that Xi holds the leverage and uses it slowly. Trump's call to Japan's Takaichi after the summit is the alliance-reassurance counterweight — Tokyo is paying attention to whether US security commitments are recalibrated under any new deal architecture.

The Iran file is the operational pivot underneath everything. Twelve weeks in, the IEA's "largest supply disruption in modern oil-market history" framing is now the consensus read; world oil demand is contracting more than 400 kb/d y-o-y; Saudi Aramco's CEO warns recovery slips into 2027 even with a ceasefire today. Germany cutting its 2026 growth forecast in half and Merz publicly distancing his family from US life are the most concrete European political consequences so far. India hiked domestic fuel prices for the first time in four years — the inflation pass-through is now visible at the consumer level in major emerging economies, with Bloomberg's "Indian households set to pay the price" capturing the human-stakes side of the macro shock.

Two adjacent threads. First, Russia/Ukraine: the Kyiv apartment-block strike with at least 24 dead — including three children — and the forensic confirmation that the Kh-101 used was built this quarter from over 100 Western components is the year's most concrete sanctions-circumvention case study. Expect the EU's 22nd sanctions package, when it lands, to focus harder on component-level chokepoints. Second, the UK: Burnham's pathway to Westminster is the cleanest live political trade in Europe, with cable and gilts carrying the discount; no UK data Monday to settle the question either way, so the political timetable is the watch item. Adjacent: Latvia's government collapsed over Russia-bound Ukrainian drones, a reminder that the European political tape is unusually noisy.

Central banks & the rate narrative

The G-7 will discuss the bond selloff this weekend with yields at multi-decade highs across several markets. The setup heading in is the rawest test for the new Fed leadership in years: the 10-year at 4.59% and the 2-year at 4.09% are both at their highest since February 2025, the curve is flattening into the front end's repricing, and SocGen has labelled the move "unhinged." Two of Trump's other Fed nominees publicly oppose keeping Powell as Chair Pro Tempore, an early signal that internal Board cohesion will be a story under Warsh. The arrangement also keeps Powell in nominal control as the next FOMC dataset prints — the calendar gives Warsh some space to settle in before the 16–17 June meeting becomes his.

Outside the US, the picture is one of inflation pressure building rather than easing. Russia's wartime economy shrank for the first time since 2023, an interesting data point but not yet a constraint. Turkey scrapped its inflation target as economic strains deepen — a clear central-bank credibility erosion. The Bank of England is expected to water down stablecoin rules after industry pressure, a separate but symptomatic note on policy bandwidth. The cleanest cross-region signal is that the disinflation narrative the soft-landing trade depended on is under genuine strain, with German wholesale prices at a three-year high and Berlin lifting its 2026 inflation forecast to 2.7%.

Big Tech, AI & corporates — week-end positioning

The AI capital story keeps widening rather than consolidating. SpaceX is reportedly filing for IPO as soon as Wednesday at a ~$1.75tn valuation with a structure designed to ensure Musk cannot be fired — investors appear to be accepting weak shareholder rights, weak governance, and a sci-fi business vision in exchange for the listing. Big Tech is going beyond Wall Street for huge AI borrowing per the FT, an obscure Japanese stock measure is widening on the global hunt for AI winners, and Anduril doubled its valuation to over $60bn. Multiverse hit a $2.1bn valuation in the AI-workforce-training niche. The counter-tells stay: Korea outflows accelerating despite the record rally; the FT reports US job losses now showing up in roles directly exposed to AI; and EY retracted a study after researchers found AI hallucinations — a credibility moment for AI-augmented professional research.

Around the deal and corporate tape: NextEra–Dominion at ~$400bn would create the largest US utility (the AI-power-demand thesis made concrete); Adani settled with the SEC on a $18m penalty, near-closing a multi-year US overhang on India's largest group; Schroders is exiting China mutual funds after three years; HSBC paused a $4bn private-credit allocation; and BlackRock's private-credit fund valuations are being scrutinised by US prosecutors — three early cracks in the private-credit narrative worth tracking. Honda–Nissan tie-up speculation revived. McKinsey is cutting partner cash share in a post-AI pay revamp — the consultancy compensation model is starting to absorb AI-driven productivity gains. Berkshire sold $8bn of Chevron as oil prices soared.

Health & science (worth a clinician's glance)

The Ebola outbreak in the Democratic Republic of Congo is the live infectious-disease story this weekend. The reporting frame — "testing Congo after US aid cuts" — captures the structural worry: the response capacity built up over a decade through PEPFAR-adjacent and global-health-security funding has been thinned this year, and the speed of the international response will determine whether this stays a regional containment story or becomes something larger. From a clinician's perspective, the case-fatality and transmission profile of Ebola has not changed; the systems story is what's new. Worth keeping an eye on WHO situation reports through the week.

FDA news: the agency swapped its top drug and vaccine regulators as part of an internal staff overhaul — a personnel move that will affect approval pipelines, advisory-committee composition and pharmacovigilance signalling over the next quarter. Worth tracking which therapeutic areas the new appointees come from. On the AI-meets-medicine front, EY retracted a study after researchers identified AI hallucinations in the methodology — a useful prompt for the broader debate about AI-assisted literature review and citation integrity in clinical research, where the consequences of fabricated references are higher than in business consulting. On the "longevity becomes consumer wellness" thread, Bloomberg covered Nvidia billionaire Mark Stevens's $175m gift for a new Bay Area medical school — the AI-fortunes-into-medical-philanthropy story is now a recognisable pattern.

Week ahead (CET)